Showing results (71-80 of 285) with videos related to
Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|January 29, 2015
Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trialsZobair M Younossi, Maria Stepanova, Patrick Marcellin, et al.Antiviral Therapy|July 1, 2010
Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort studyJean-Philippe Lang, Pascal Melin, Denis Ouzan, et al.Ultrasound in Medicine & Biology|September 28, 2010
Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causesMagali Sasso, Michel Beaugrand, Victor de Ledinghen, et al.Journal of Hepatology|November 17, 2009
Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patientsPatrick Marcellin, Robert G Gish, Norman Gitlin, et al.Hepatology (Baltimore, Md.)|September 26, 2002
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative studyPierre Pradat, Alfredo Alberti, Thierry Poynard, et al.Antiviral Therapy|May 22, 2012
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirinDominique Larrey, Christophe Carenco, Dominique Guyader, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2014
Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis BPatrick Marcellin, Michelle Martinot-Peignoux, Tarik Asselah, et al.Hepatology (Baltimore, Md.)|November 18, 2009
Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosisSavino Bruno, Mitchell L Shiffman, Stuart K Roberts, et al.Annals of Hepatology|June 14, 2014
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCVMaribel Rodriguez-Torres, Eric M Yoshida, Patrick Marcellin, et al.Journal of Gastroenterology and Hepatology|August 5, 2014
Severity of liver disease among chronic hepatitis C patients: an observational study of 4594 patients in five European countriesPatrick Marcellin, Kelly Grotzinger, Dickens Theodore, et al.Pageof 29